205 related articles for article (PubMed ID: 29747160)
1. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
Pittala S; Krelin Y; Shoshan-Barmatz V
Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
[TBL] [Abstract][Full Text] [Related]
2. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus.
Pittala S; Levy I; De S; Kumar Pandey S; Melnikov N; Hyman T; Shoshan-Barmatz V
Cells; 2020 Feb; 9(2):. PubMed ID: 32093016
[TBL] [Abstract][Full Text] [Related]
3. A Mitochondrial VDAC1-Based Peptide Greatly Suppresses Steatosis and NASH-Associated Pathologies in a Mouse Model.
Pittala S; Krelin Y; Kuperman Y; Shoshan-Barmatz V
Mol Ther; 2019 Oct; 27(10):1848-1862. PubMed ID: 31375359
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.
Shteinfer-Kuzmine A; Arif T; Krelin Y; Tripathi SS; Paul A; Shoshan-Barmatz V
Oncotarget; 2017 May; 8(19):31329-31346. PubMed ID: 28412744
[TBL] [Abstract][Full Text] [Related]
5. Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy.
Shteinfer-Kuzmine A; Amsalem Z; Arif T; Zooravlov A; Shoshan-Barmatz V
Mol Oncol; 2018 Jun; 12(7):1077-1103. PubMed ID: 29698587
[TBL] [Abstract][Full Text] [Related]
6. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
7. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
8. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
9. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
10. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
11. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.
Sun Y; Wang Q; Zhang Y; Geng M; Wei Y; Liu Y; Liu S; Petersen RB; Yue J; Huang K; Zheng L
J Hepatol; 2020 Sep; 73(3):603-615. PubMed ID: 32593682
[TBL] [Abstract][Full Text] [Related]
12. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
13. Voltage-dependent anion channel 1 (VDAC1) overexpression alleviates cardiac fibroblast activation in cardiac fibrosis via regulating fatty acid metabolism.
Tian G; Zhou J; Quan Y; Kong Q; Li J; Xin Y; Wu W; Tang X; Liu X
Redox Biol; 2023 Nov; 67():102907. PubMed ID: 37797372
[TBL] [Abstract][Full Text] [Related]
14. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G
World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661
[TBL] [Abstract][Full Text] [Related]
15. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
16. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
17. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
[TBL] [Abstract][Full Text] [Related]
18. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
19. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of echinacoside in hepatocellular carcinoma mouse model and HepG2 cells.
Ye Y; Song Y; Zhuang J; Wang G; Ni J; Xia W
J Cell Physiol; 2019 Feb; 234(2):1880-1888. PubMed ID: 30067868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]